ProQR Therapeutics N.V. SEC filings PRQR
ProQR Therapeutics N.V. has 391 filings in SEC EDGAR's recent list, going back to Jul 11, 2014. Its latest annual report, Form 20-F, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K/A | Form 6-k/a | Oct 30, 2026 | Oct 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 28, 2026 | Oct 28, 2026 |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 29, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 24, 2026 | — |
| 4 | Insider transaction | Jul 21, 2026 | Jul 17, 2026 |
| EFFECT | Filing | Jul 15, 2026 | — |
| 424B5 | Prospectus supplement | Jul 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 15, 2026 | — |
| 4 | Insider transaction | Jul 13, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| F-3 | Shelf registration (foreign issuer) | Jul 6, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 30, 2026 | — |
| 4/A | Ownership document | Jun 30, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 6-K | Current report (foreign issuer) | Jun 26, 2026 | Jun 26, 2026 |
| 424B5 | Prospectus supplement | Jun 26, 2026 | — |
| 6-K | Current report (foreign issuer) | Jun 25, 2026 | Jun 25, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 3, 2026 | — |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
| 3 | Initial insider ownership | Jun 2, 2026 | Jun 2, 2026 |
| 6-K | Current report (foreign issuer) | May 12, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | May 12, 2026 | May 12, 2026 |
| 6-K | Current report (foreign issuer) | May 4, 2026 | May 4, 2026 |
| 6-K | Current report (foreign issuer) | Apr 30, 2026 | Apr 30, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 6-K | Current report (foreign issuer) | Mar 25, 2026 | Mar 25, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 20-F | Annual report (foreign issuer) | Mar 12, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 12, 2026 | Mar 12, 2026 |
| 6-K | Current report (foreign issuer) | Feb 9, 2026 | Feb 9, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 20, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 8, 2026 | Jan 8, 2026 |
| 6-K | Current report (foreign issuer) | Nov 6, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Nov 3, 2025 | Nov 3, 2025 |
| 6-K | Current report (foreign issuer) | Oct 20, 2025 | Oct 20, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 30, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 4, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 20, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Jun 26, 2025 | Jun 26, 2025 |
| 6-K | Current report (foreign issuer) | Jun 3, 2025 | Jun 3, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | May 28, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 6-K | Current report (foreign issuer) | May 8, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | May 1, 2025 | May 1, 2025 |
| 6-K | Current report (foreign issuer) | Apr 14, 2025 | Apr 14, 2025 |
| EFFECT | Filing | Mar 25, 2025 | — |
| 424B5 | Prospectus supplement | Mar 25, 2025 | — |
| CORRESP | Letter to the SEC | Mar 21, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 13, 2025 | — |
| 20-F | Annual report (foreign issuer) | Mar 13, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 13, 2025 | Mar 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2025 | — |
| 6-K/A | Form 6-k/a | Dec 12, 2024 | Dec 12, 2024 |
| 6-K | Current report (foreign issuer) | Dec 11, 2024 | Dec 11, 2024 |
| 6-K | Current report (foreign issuer) | Dec 11, 2024 | Dec 11, 2024 |
| 6-K | Current report (foreign issuer) | Dec 10, 2024 | Dec 10, 2024 |
| 6-K | Current report (foreign issuer) | Dec 5, 2024 | Dec 5, 2024 |
| 6-K | Current report (foreign issuer) | Nov 7, 2024 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Oct 25, 2024 | Oct 25, 2024 |
| 424B5 | Prospectus supplement | Oct 24, 2024 | — |
| 424B5 | Prospectus supplement | Oct 23, 2024 | — |
| EFFECT | Filing | Oct 10, 2024 | — |
| 424B5 | Prospectus supplement | Oct 10, 2024 | — |
| CORRESP | Letter to the SEC | Oct 8, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 30, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 8, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | May 22, 2024 | May 22, 2024 |
| 6-K | Current report (foreign issuer) | May 9, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 23, 2024 | Apr 23, 2024 |
| 6-K | Current report (foreign issuer) | Apr 19, 2024 | Apr 19, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 13, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 13, 2024 | Mar 13, 2024 |
| 6-K | Current report (foreign issuer) | Feb 15, 2024 | Feb 15, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 6-K | Current report (foreign issuer) | Jan 19, 2024 | Jan 19, 2024 |
| 6-K | Current report (foreign issuer) | Jan 5, 2024 | Jan 5, 2024 |
| 6-K | Current report (foreign issuer) | Dec 8, 2023 | Dec 8, 2023 |
| 6-K | Current report (foreign issuer) | Nov 7, 2023 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Sep 27, 2023 | Sep 27, 2023 |
| SC 13G | Ownership over 5% (passive) | Sep 14, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 3, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 1, 2023 | Aug 1, 2023 |
| 6-K | Current report (foreign issuer) | May 17, 2023 | May 17, 2023 |
| 6-K | Current report (foreign issuer) | May 16, 2023 | Mar 31, 2023 |
| EFFECT | Filing | Apr 24, 2023 | — |
| 424B5 | Prospectus supplement | Apr 24, 2023 | — |
| CORRESP | Letter to the SEC | Apr 20, 2023 | — |
| 6-K | Current report (foreign issuer) | Apr 18, 2023 | Apr 18, 2023 |
| UPLOAD | Letter from the SEC | Apr 4, 2023 | — |
| RW | Filing | Mar 29, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 29, 2023 | — |
| 20-F | Annual report (foreign issuer) | Mar 29, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 29, 2023 | Mar 29, 2023 |
| 6-K | Current report (foreign issuer) | Mar 10, 2023 | Mar 10, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 23, 2022 | — |
| 6-K | Current report (foreign issuer) | Dec 23, 2022 | Dec 23, 2022 |
| 6-K | Current report (foreign issuer) | Nov 9, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Sep 21, 2022 | Sep 21, 2022 |
| 6-K | Current report (foreign issuer) | Aug 11, 2022 | Aug 11, 2022 |
| 6-K | Current report (foreign issuer) | Aug 4, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jun 30, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Jun 1, 2022 | Jun 1, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | May 9, 2022 | — |
| 6-K | Current report (foreign issuer) | May 5, 2022 | Mar 31, 2022 |
| 20-F | Annual report (foreign issuer) | Apr 29, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Apr 13, 2022 | Apr 13, 2022 |
| 6-K | Current report (foreign issuer) | Apr 13, 2022 | Apr 13, 2022 |
| 424B5 | Prospectus supplement | Mar 10, 2022 | — |
| EFFECT | Filing | Mar 9, 2022 | — |
| CORRESP | Letter to the SEC | Mar 7, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 1, 2022 | — |
| 6-K | Current report (foreign issuer) | Feb 24, 2022 | Dec 31, 2021 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| 6-K | Current report (foreign issuer) | Feb 11, 2022 | Feb 11, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 4, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 4, 2022 | — |
| 6-K | Current report (foreign issuer) | Jan 4, 2022 | Jan 4, 2022 |
| 6-K | Current report (foreign issuer) | Dec 30, 2021 | Dec 30, 2021 |
| 6-K | Current report (foreign issuer) | Dec 16, 2021 | Dec 16, 2021 |
| 6-K | Current report (foreign issuer) | Nov 18, 2021 | Nov 18, 2021 |
| 6-K | Current report (foreign issuer) | Nov 18, 2021 | Nov 18, 2021 |
| 424B5 | Prospectus supplement | Nov 17, 2021 | — |
| 424B5 | Prospectus supplement | Nov 17, 2021 | — |
| EFFECT | Filing | Nov 16, 2021 | — |
| CORRESP | Letter to the SEC | Nov 12, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2021 | — |
| S-8 | Employee stock plan registration | Nov 4, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 4, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Nov 4, 2021 | — |
| 6-K | Current report (foreign issuer) | Nov 4, 2021 | Sep 30, 2021 |
| 6-K | Current report (foreign issuer) | Oct 4, 2021 | Oct 4, 2021 |
| SC 13G | Ownership over 5% (passive) | Sep 10, 2021 | — |
| 6-K | Current report (foreign issuer) | Sep 9, 2021 | Sep 9, 2021 |
| 6-K | Current report (foreign issuer) | Sep 8, 2021 | Sep 8, 2021 |
| 6-K | Current report (foreign issuer) | Aug 5, 2021 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Jul 8, 2021 | Jul 8, 2021 |
| 6-K | Current report (foreign issuer) | May 20, 2021 | May 20, 2021 |
| 6-K | Current report (foreign issuer) | May 6, 2021 | May 6, 2021 |
| 6-K | Current report (foreign issuer) | May 4, 2021 | May 31, 2021 |
| 6-K | Current report (foreign issuer) | Apr 20, 2021 | Apr 20, 2021 |
| 6-K | Current report (foreign issuer) | Apr 6, 2021 | Apr 6, 2021 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 6, 2021 | — |
| 6-K | Current report (foreign issuer) | Apr 1, 2021 | Apr 1, 2021 |
| 424B5 | Prospectus supplement | Apr 1, 2021 | — |
| 424B5 | Prospectus supplement | Apr 1, 2021 | — |
| 424B5 | Prospectus supplement | Mar 30, 2021 | — |
| 20-F | Annual report (foreign issuer) | Mar 24, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Mar 24, 2021 | Mar 24, 2021 |
| 6-K | Current report (foreign issuer) | Mar 24, 2021 | Mar 24, 2021 |
| 6-K | Current report (foreign issuer) | Feb 25, 2021 | Dec 31, 2020 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 3, 2021 | — |
| 6-K | Current report (foreign issuer) | Jan 7, 2021 | Jan 7, 2021 |
| 6-K | Current report (foreign issuer) | Nov 16, 2020 | Sep 30, 2020 |
| 6-K | Current report (foreign issuer) | Oct 5, 2020 | Oct 5, 2020 |
| 424B5 | Prospectus supplement | Sep 22, 2020 | — |
| EFFECT | Filing | Sep 18, 2020 | — |
| CORRESP | Letter to the SEC | Sep 16, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 11, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRQR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Leiden
- SEC filer status
- Accelerated filer
- SEC CIK
- 1612940
- Former names
- ProQR Therapeutics B.V. (until Oct 3, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.